Successful private placement and retail offering - Zelluna ASA raises NOK 58 million to advance the world’s first 'off-the-shelf” TCR-NK therapy, ZI-MA4-1, into Phase I clinical trials and develop the ...
CarBuzz on MSN
America's Failed Luxury Cars Are Still Evolving In China
The Cadillac CT6 almost feels like a distant memory now, but at one point, it was GM's ambitious attempt to take on the ...
Shares in the US technology giant rose another 6% to $259 in early trading in New York following a near-10% jump on Friday.
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback